심장 AI 모니터링 및 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cardiac AI Monitoring and Diagnostics Market size is expected to reach USD 14.32 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 27.41% during 2026-2034.

The Global Cardiac AI Monitoring and Diagnostics Market is growing rapidly due to increasing cardiovascular disease prevalence worldwide. Artificial intelligence enhances diagnostic accuracy by analyzing large volumes of cardiac data efficiently. Rising adoption of wearable devices and remote patient monitoring systems further fuels market growth. Healthcare providers are increasingly leveraging AI to improve early detection and treatment outcomes.

Key drivers include advancements in machine learning algorithms and integration of AI with imaging technologies. Growing demand for predictive analytics in cardiology enhances clinical decision-making. Expansion of telehealth services and digital health platforms supports market development. Increased healthcare investments and regulatory support for AI-based medical solutions further strengthen growth prospects.

Looking ahead, continuous innovation in real-time monitoring and cloud-based analytics will expand applications. Emerging economies adopting digital health infrastructure will create new growth opportunities. Integration of AI with advanced imaging and wearable technology will improve preventive care. As healthcare systems focus on data-driven diagnostics, cardiac AI solutions are expected to gain widespread adoption.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware
• Software solutions
• Services

By Type

• Cardiac diagnostics
• Cardiac monitoring

By Application

• Cardiac arrhythmias
• Stroke
• Ischemic heart disease
• Stenosis
• Other applications

By End-use

• Hospitals
• Specialty clinics
• Diagnostic centers
• Research and academic institute

COMPANIES PROFILED

• CardiAI Inc, Cleerly Inc, DiA Imaging Analysis Ltd, HeartVista Inc, IDOVEN, Koninklijke Philips NV, RSIP Vision, Tempus Labs Inc, UltraSight Ltd, Ultromics Limited, Vizai Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Cardiac diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiac arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ischemic heart disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Specialty clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research and academic institute Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIAC AI MONITORING AND DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CardiAI Inc
  • 10.2.2 Cleerly Inc
  • 10.2.3 DiA Imaging Analysis Ltd
  • 10.2.4 HeartVista Inc
  • 10.2.5 IDOVEN
  • 10.2.6 Koninklijke Philips N.V
  • 10.2.7 RSIP Vision
  • 10.2.8 Tempus Labs Inc
  • 10.2.9 UltraSight Ltd
  • 10.2.10 Ultromics Limited
  • 10.2.11 Viz.Ai Inc